A deal that gives the US zero tariffs on its imports of UK pharmaceuticals in return for the NHS raising spending on medicines will cost around £1 billion, Downing Street has said.
The agreement sees the UK’s threshold for what it can pay for new medicines raised by 25%, meaning some that would have been declined as too costly can be approved – such as breakthrough cancer treatments and therapies for rare diseases.
